Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

BACKGROUND: Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to investiga...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Chen, Chaojiang, Cai, Zhiduan, Zhuo, Yangjia, Xi, Ming, Lin, Zhuoyuan, Jiang, Funeng, Liu, Zezhen, Wan, Yueping, Zheng, Yu, Li, Jianxin, Zhou, Xing, Zhu, Jianguo, Zhong, Weide
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137497/
https://ncbi.nlm.nih.gov/pubmed/32252682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06776-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak